Boston Bioprocess is a US-based startup established in 2022 that focuses on assisting biotech companies in developing, scaling up, and optimizing fermentation and DSP (Downstream Processing) processes. The company aims to address the knowledge and capacity bottlenecks commonly encountered during the transition from laboratory-scale operations to mass commercial production in industries such as Biopharma, Biotechnology, Food and Beverage, Manufacturing, and Renewable Energy.
With a mission to facilitate the scalability of fermentation product companies, Boston Bioprocess positions itself as a valuable partner in the biotech industry. Its commitment to addressing key pain points in the journey from lab to commercial production signifies potential for substantial impact and market relevance.
There is no investment information
No recent news or press coverage available for Boston Bioprocess.